PTAFR Antikörper (Extracellular, Loop 3)
Kurzübersicht für PTAFR Antikörper (Extracellular, Loop 3) (ABIN7887006)
Target
Alle PTAFR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 259-274, Extracellular, Loop 3
-
Verwendungszweck
- A Rabbit Polyclonal antibody to Platelet-activating factor receptor (extracellular)
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Homologie
- Rat - identical,Human - 13 out of 16 amino acid residues identical
-
Produktmerkmale
- Extracellular, 3rd loop
-
Aufreinigung
- Affinity purified on immobilized antigen.
-
Immunogen
- (C)ELGYQTNFHQAINDAH, corresponding to amino acid residues 259 - 274 of mouse PTAFR
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB: 1:500
FC: 2.5 μg per reaction
ICC: The optimal concentration should be determined by the user
IHC: 1:300
IP: The optimal concentration should be determined by the user
-
Kommentare
-
Negative Control: (ABIN7236256)
Blocking Peptide: (ABIN7236256)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- 25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.
-
Konzentration
- 0.8 mg/mL
-
Buffer
- PBS pH 7.4, 1 % BSA with 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
-
-
- PTAFR (Platelet-Activating Factor Receptor (PTAFR))
-
Andere Bezeichnung
- PTAFR
-
Hintergrund
-
Synonyms: PTAFR, PAFR
Description: Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a biologically active phospholipid mediator that was first described by its ability to cause platelet aggregation and dilation of blood vessels. In addition, PAF acts as a mediator of cell-to-cell communication, inflammation, allergic responses and shock1. PAF acts on PAF receptor (PAFR) a G protein-coupled receptor (GPCR). It consists of 7 transmembrane-spanning domains (TMDs), and two potential N-linked glycosylation sites. PAFR was found to expressed in the lung, neutrophils, monocytes, macrophages, placenta, small intestine, heart, liver, kidney, brain, and spleen. As a results of PAF interaction, PAFR is coupled to Gq protein and consequently activates various downstream signaling pathways2. Experiments in both PAF receptor knockout animals and transgenic animals overexpressing PAF receptors support the pathophysiological role attributed to PAF receptor signaling. For example, Mice model of obstructive nephropathy show that PAFR signaling contributes to a pro-inflammatory environment leading to renal dysfunction and progressive organ failure3. In addition, inhibition of PAFR signaling results in an effective inhibition of experimental tumor growth and metastasis4.
-
Gen-ID
- 19204
-
NCBI Accession
- NM_000952
-
UniProt
- Q62035
-
Pathways
- Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin
Target
-